1. Introduction
Hyperplasia of the gingiva, clinically referred to as gingival overgrowth or gingival enlargement, is a condition characterized by an abnormal increase in the size of the gum tissue surrounding the teeth. The healthy gingiva serves as a firm, protective collar around the cervical portion of the teeth and the underlying alveolar bone. When this tissue undergoes hyperplastic changes, it expands outward and upward, often encroaching upon the clinical crowns of the teeth. This enlargement creates deep pseudopockets that complicate oral hygiene, fostering an environment prone to severe periodontal infection and progressive bone loss.
The condition poses significant functional and aesthetic challenges. In severe cases, the overgrown tissue can interfere with speech, mastication, and proper lip closure, while the altered appearance often causes considerable psychological distress. The etiology of gingival hyperplasia is multifactorial, encompassing chronic inflammatory responses, systemic hormonal shifts, specific genetic predispositions, and adverse reactions to several classes of systemic medications. Effective clinical management requires a precise diagnosis of the underlying cause, rigorous mechanical plaque control, adjustments to the patient’s pharmacological regimen, and frequently, surgical excision to restore normal gingival architecture.
2. Anatomy and Histology of the Gingiva
To understand the pathology of gingival overgrowth, an overview of normal gingival anatomy is necessary. The gingiva is composed of a dense core of fibrous connective tissue covered by stratified squamous epithelium. The connective tissue, or lamina propria, is rich in collagen fibers, extracellular matrix, and specialized cells known as fibroblasts, which are responsible for synthesizing and remodeling the structural proteins.
In true gingival hyperplasia, the fundamental biological defect involves an imbalance in the turnover of this connective tissue. The gingival fibroblasts become abnormally active, synthesizing collagen and extracellular matrix components at a rate that vastly exceeds the rate of enzymatic degradation. This results in the massive accumulation of dense, fibrotic tissue within the lamina propria. Concurrently, the overlying epithelium may become thickened (acanthosis) with elongated rete pegs extending deep into the connective tissue.
3. Plaque-Induced Inflammatory Enlargement
The most common contributing factor to any form of gingival enlargement is plaque-induced inflammation. Bacterial plaque continuously accumulates along the gingival margin. If not removed through diligent brushing and flossing, the bacteria release toxins that penetrate the gingival epithelium, triggering a robust local immune response.
This chronic inflammatory response results in significant vasodilation, edema, and the infiltration of inflammatory cells. The gingiva becomes swollen, red, and bleeds easily upon probing. While this simple inflammatory enlargement is technically an edema rather than true cellular hyperplasia, chronic inflammation creates a biological environment that stimulates fibroblast activity, directly contributing to fibrotic tissue overgrowth over time.
4. Medication-Induced Gingival Hyperplasia
A substantial proportion of true fibrotic gingival hyperplasia is iatrogenic, meaning it is an unintended side effect of specific systemic medications. These medications fundamentally alter the calcium metabolism within the gingival fibroblasts, impairing the cellular production of collagenase, the enzyme responsible for breaking down excess collagen.
When collagen production continues but degradation halts, the connective tissue rapidly expands. The enlargement typically begins at the interdental papillae, the triangular peaks of gum tissue between the teeth, and slowly spreads across the facial and lingual surfaces of the dentition. The severity of the medication-induced overgrowth is intricately linked to the patient’s level of oral hygiene; the presence of bacterial plaque significantly exacerbates the fibrotic response to the medication.
5. Classes of Offending Medications
Three primary classes of systemic medications are well-documented to induce gingival hyperplasia.
The first class includes anticonvulsant medications, most notably phenytoin, which is utilized for the management of epilepsy. Phenytoin-induced hyperplasia occurs in approximately fifty percent of patients utilizing the drug long-term. The second class comprises immunosuppressants, primarily cyclosporine, which is essential for preventing organ rejection in transplant recipients and managing severe autoimmune diseases. The third class includes calcium channel blockers, such as nifedipine, amlodipine, and verapamil, which are widely prescribed for the treatment of hypertension and angina.
6. Systemic and Hormonal Influences
Systemic conditions and physiological hormonal shifts can dramatically alter the tissue response to local bacterial plaque, resulting in pronounced gingival enlargement.
During pregnancy, the exponential rise in circulating estrogen and progesterone increases vascular permeability in the gingival tissues and alters the subgingival microbial flora. This heightened sensitivity frequently leads to a condition known as pregnancy gingivitis, which can present with significant, localized nodular enlargements called pyogenic granulomas. Similar, though less severe, hormonal enlargements can occur during puberty or in patients utilizing high-dose oral contraceptives. Furthermore, severe vitamin C deficiency (scurvy) impairs collagen synthesis, leading to swollen, spongy, and easily bleeding gums.
7. Hyperplasia Associated with Leukemia
In rare instances, generalized gingival enlargement serves as an early clinical manifestation of an underlying systemic malignancy, most notably acute myeloid leukemia.
In leukemic gingival enlargement, the increase in tissue volume is not driven by fibrotic collagen deposition, but rather by the massive, dense infiltration of malignant white blood cells directly into the gingival connective tissue. The gums appear markedly swollen, severely erythematous, and possess a shiny surface. The tissue is exceedingly friable and bleeds spontaneously or with the slightest provocation. Recognizing this specific presentation is critical, as a prompt referral for hematological evaluation is life-saving.
8. Hereditary Gingival Fibromatosis
Hereditary gingival fibromatosis is a rare, slow-growing, benign genetic condition characterized by a generalized, profound fibrotic enlargement of the gingiva. It typically follows an autosomal dominant inheritance pattern.
The overgrowth usually begins to manifest during the eruption of the permanent dentition in childhood or early adolescence. The tissue is characteristically firm, pale pink, non-tender, and exhibits an extreme stippled (orange-peel) texture. The massive fibrotic tissue can completely cover the crowns of the teeth, severely delaying or entirely preventing normal tooth eruption. Unlike medication-induced hyperplasia, this hereditary form occurs even in the presence of impeccable oral hygiene and the complete absence of local inflammation.
9. Clinical Symptoms and Complications
The primary symptom is the visible, bulbous enlargement of the gingival margins and interdental papillae. As the tissue grows, it creates pseudopockets—deep crevices between the overgrown gum and the tooth surface that the patient cannot physically reach with a toothbrush or floss.
These pseudopockets rapidly become colonized by anaerobic periodontal pathogens. The resulting severe, localized infection destroys the periodontal ligament and the supporting alveolar bone, transforming the overgrowth into severe periodontitis. The patient experiences chronic halitosis, altered taste, and significant gingival bleeding. Additionally, the bulky tissue impedes normal oral function, making chewing painful and often forcing the teeth out of their proper alignment.
10. Diagnostic Periodontal Assessment
A comprehensive periodontal examination is required to establish the diagnosis and plan appropriate therapy. The dentist or periodontist utilizes a periodontal probe to measure the depth of the pseudopockets and assess the degree of clinical attachment loss.
A thorough medical and pharmacological history is vital to identify any offending medications or systemic conditions. Radiographic imaging, typically a full mouth series of periapical X-rays, is performed to evaluate the underlying crestal bone levels and determine if the hyperplastic tissue has contributed to permanent periodontal bone destruction. If the presentation is atypical, asymmetrical, or fails to respond to initial therapy, a surgical biopsy of the gingival tissue is mandated to rule out malignancy or specialized fibrotic diseases.
11. Differential Diagnosis of Gingival Enlargement
Determining the exact etiology is crucial, as the therapeutic approach varies significantly between the different forms of enlargement.
| Etiology | Distinguishing Clinical Characteristics |
|---|---|
| Medication-Induced | Firm, nodular overgrowth starting at the interdental papillae; correlates with specific drug usage. |
| Inflammatory (Plaque) | Soft, edematous, deep red or bluish-red tissue that bleeds profusely; resolves with deep cleaning. |
| Hereditary Fibromatosis | Extremely firm, dense, pale pink tissue covering the crowns; positive family history; begins in youth. |
| Leukemic Infiltration | Spontaneous bleeding, severely swollen, shiny tissue accompanied by systemic fatigue and pallor. |
12. Non-Surgical Periodontal Therapy
The initial phase of treatment for virtually all cases of gingival hyperplasia involves rigorous, non-surgical periodontal therapy to eliminate the bacterial plaque and calculus that drive the inflammatory component of the disease.
This phase includes professional scaling and root planing, commonly referred to as a deep cleaning. The dental professional utilizes ultrasonic and hand instruments to meticulously remove mineralized deposits from beneath the gum line. The patient is provided with intensive oral hygiene instruction, emphasizing meticulous brushing techniques and interdental cleaning. Antimicrobial mouth rinses, such as chlorhexidine gluconate, are frequently prescribed to reduce the bacterial load within the deep pseudopockets.
13. Pharmacological Adjustments
If the hyperplastic tissue is driven by a systemic medication, mechanical cleaning alone will be insufficient. The periodontist must collaborate closely with the patient’s primary care physician or cardiologist to discuss pharmacological alternatives.
For example, a patient experiencing amlodipine-induced overgrowth may be safely transitioned to an angiotensin receptor blocker or a diuretic, which do not possess the side effect of gingival fibrosis. If a medication substitution is safely achieved, the gingival overgrowth frequently arrests and may partially regress over several months. However, if the medication is life-saving and cannot be substituted (as is often the case with cyclosporine post-transplant), the dental team must rely on aggressive surgical management.
14. Surgical Intervention: Gingivectomy
When the fibrotic tissue fails to regress following non-surgical therapy and medication adjustments, surgical excision is required to restore a healthy, maintainable oral environment. The most common procedure is a gingivectomy.
Performed under local anesthesia, the periodontist utilizes a scalpel, electrosurgery, or a dental laser to precisely sculpt and remove the excess fibrotic tissue, re-establishing the normal physiological contour of the gum line. The laser approach is particularly beneficial as it simultaneously cuts and coagulates the tissue, minimizing bleeding and reducing post-operative discomfort. By eliminating the deep pseudopockets, the surgery allows the patient to resume effective daily plaque control.
15. Periodontal Flap Surgery
In advanced cases where the hyperplasia has contributed to significant underlying bone loss, a simple gingivectomy is inadequate. A more comprehensive procedure known as periodontal flap surgery is indicated.
The periodontist makes precise incisions to separate the gingival tissue from the teeth and folds it back, providing direct visual access to the damaged bone and the deeper root surfaces. The roots are thoroughly debrided, and the bony defects may be treated with bone grafts or regenerative proteins. The tissue is then trimmed of any excess hyperplastic mass, repositioned at a healthier level, and sutured securely in place.
16. When to Consult a Healthcare Provider
A patient should schedule an appointment with a dentist if they notice their gums appearing swollen, growing over the surface of their teeth, or bleeding consistently during normal brushing.
Immediate medical and dental consultation is required if the gum enlargement appears suddenly, grows rapidly, is accompanied by unexplained bruising on the body, or if the patient experiences severe systemic fatigue. These red flag symptoms may indicate a serious underlying systemic condition, such as leukemia, demanding urgent hematological evaluation prior to any dental instrumentation.
17. Frequently Asked Questions (FAQ)
1. Will the overgrown gum tissue shrink if I start brushing better?
If the enlargement is purely inflammatory and caused by plaque, exceptional oral hygiene and a professional cleaning will significantly reduce the swelling. However, if the tissue has become dense and fibrotic due to medications, brushing alone will not shrink it, and surgery will be necessary.
2. Should I stop taking my blood pressure medicine if my gums are growing?
No. You must never discontinue a prescribed systemic medication without explicit instructions from your physician. Your dentist will consult with your doctor to find a safe alternative medication that does not cause the side effect.
3. Is gingival hyperplasia a form of oral cancer?
No. Gingival hyperplasia is a benign, non-cancerous overgrowth of connective tissue. While it can look alarming and cause functional problems, it does not spread to other parts of the body like a malignancy.
4. Will the gums grow back after the surgery?
The recurrence rate depends heavily on the underlying cause. If you continue to take the offending medication and have poor oral hygiene, the tissue will likely regrow. Maintaining excellent home care significantly delays or prevents recurrence.
5. How long is the recovery after a gingivectomy?
The initial healing of the superficial tissue typically takes one to two weeks. You may experience mild to moderate discomfort for a few days, managed with soft foods and over-the-counter pain relievers, but normal activities can usually be resumed within a day.
18. Bibliography
Disclaimer: The content is for informational purposes only and does not replace medical advice. Always consult your doctor for personalized treatment.
